COUGH MONITORING WITH STRADOS LABS
Cough and Lung Sound Measurement
The advanced, fit-for-purpose wearable for respiratory drug development and clinical trials
FDA 510(k) Class II Device | CE Mark | HIPAA Compliant
Technology Overview
- The RESP Biosensor remotely captures 24-hour cough and lung sounds (wheeze, crackles, rhonchi) with exceptional clinical accuracy*
- Reduces site and patient burden with its wireless, lightweight design and seamless data sync to the cloud
- Collects objective, quantifiable data on respiratory symptoms from screening subjects to the research phases
*Results of Clinical Performance Testing in Chronic Lung Diseases, 2022 ATS Abstract
RESP Biosensor Measurements
Cough
Frequency and Severity
Lung Sounds
Wheeze, Rhonchi, Crackles
Additional Measures*
Respiratory rate, Activity level, Sleep/Wake
*Not yet cleared by the FDA
Strengthen Your Insight and Evidence Across Multiple Therapeutic Areas
- Chronic Cough
- Pulmonary Fibrosis
- Chronic Bronchitis
- COPD & Asthma
- Infectious Diseases
- Congestive Heart Failure
The RESP Biosensor offers a patient-friendly, efficient approach to 24-hour ambulatory cough monitoring from screening subjects to the research phases. Strados Labs’ consensus labeling process ensures the highest level of accuracy in coughs counted.
Our technology also allows researchers to collect additional parameters beyond frequency that can reveal greater insights into patient quality of life, including cough intensity, spasms and bouts, sleep/wake*, body positioning* and activity level.*
Coughing and lung sounds such as crackles are strongly associated with IPF and ILD. The RESP Biosensor enables 24-hour monitoring of these symptoms to help researchers gain objective insight into treatment response in addition to subjective tools such as VAS and the Leicester Cough Questionnaire.
Cough is one of the primary symptoms of bronchitis with 24-hour cough monitoring frequently used to demonstrate treatment efficacy. The RESP Biosensor offers a more patient-friendly approach to cough monitoring for bronchitis with the ability to capture additional insights.
The RESP Biosensor allows researchers to objectively measure cough, lung sounds including wheeze and shortness of breath* in patients with COPD and Asthma, supplementing traditional measures such as spirometry and the COPD Assessment Test, Asthma Control Questionnaire, and the St. George’s Respiratory Questionnaire.
Infectious diseases such as COVID-19 and RSV impact the lungs and produce symptoms such as coughing, wheezing and shortness of breath. The RESP Biosensor can offer additional insight into how infectious disease therapies perform by measuring their impact on respiratory health.
Respiratory-related symptoms such as coughing, wheezing, and shortness of breath as well as crackles are common among Heart Failure patients. The RESP Biosensor offers an objective way for clinical trialists to objectively measure these symptoms.
*Measurement not FDA-cleared
Why the RESP Biosensor for Cough Monitoring?
Privacy & Security
End-to-end encryption and noise filtering ensure patient privacy is protected.
Wireless Data Sync
Access patient results faster with real-time data transfer to the cloud.
Patient-Friendly
Lightweight and discreet biosensor that doesn’t alter daily routines.
Beyond Count
Collect additional parameters beyond frequency such as intensity, spasms, and activity* to gain more context.
Data Reporting
Patient recordings are transferred to the cloud for processing and analysis by our team. Proprietary machine learning algorithms are used to provide varying levels of automation in the annotation process.*
*Machine learning algorithms not cleared by FDA
Request a Demo
Explore partnering with us for your next trial